Stock CENGILD CENGILD MEDICAL
Add to a list
To use this feature you must be a member
Log inSign up

Financials Cengild Medical

Equities

CENGILD

MYQ0243OO004

Healthcare Facilities & Services

End-of-day quote BURSA MALAYSIA
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.31 MYR +1.64% Intraday chart for Cengild Medical +1.64% -7.46%
Apr. 22 Cengild Medical Berhad Announces Resignation of Mr. Micheal Bong Enn Chung @ Micheal Wong Enn Chung as the Group Chief Executive Officer CI
Apr. 22 Cengild Medical Berhad Appoints Miss Yap Soh Kim as the Acting Chief Executive Officer CI

Valuation

Fiscal Period: June 2022 2023
Capitalization 1 327.5 329
Enterprise Value (EV) 1 256.7 244.9
P/E ratio 27.4 x 24.5 x
Yield 0.93% 1.87%
Capitalization / Revenue 5.08 x 4.68 x
EV / Revenue 3.98 x 3.48 x
EV / EBITDA 17.6 x 15 x
EV / FCF 21,160,260 x 26,115,473 x
FCF Yield 0% 0%
Price to Book 3.52 x 3.1 x
Nbr of stocks (in thousands) 818,800 832,874
Reference price 2 0.4000 0.3950
Announcement Date 10/28/22 10/31/23
1MYR in Million2MYR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Juni 2018 2019 2020 2021 2022 2023
Net sales 1 11.68 28.18 39.18 63.47 64.44 70.28
EBITDA 1 -0.263 6.19 9.924 17.73 14.56 16.33
EBIT 1 -2.211 3.513 7.02 14.63 11.57 14.46
Operating Margin -18.93% 12.47% 17.92% 23.05% 17.95% 20.58%
Earnings before Tax (EBT) 1 -4.14 1.476 5.534 13.47 12.11 17.37
Net income 1 -4.14 1.476 3.952 10 9.391 13.29
Net margin -35.44% 5.24% 10.09% 15.76% 14.57% 18.91%
EPS 2 -0.3312 0.1181 0.3162 0.0167 0.0146 0.0161
Free Cash Flow - 2.589 8.561 9.818 12.13 9.377
FCF margin - 9.19% 21.85% 15.47% 18.82% 13.34%
FCF Conversion (EBITDA) - 41.83% 86.27% 55.39% 83.28% 57.44%
FCF Conversion (Net income) - 175.36% 216.63% 98.14% 129.16% 70.57%
Dividend per Share - - - - 0.003700 0.007400
Announcement Date 3/30/22 3/30/22 3/30/22 3/30/22 10/28/22 10/31/23
1MYR in Million2MYR
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 35 31.7 22.6 17.2 - -
Net Cash position 1 - - - - 70.9 84.1
Leverage (Debt/EBITDA) -133 x 5.128 x 2.279 x 0.9696 x - -
Free Cash Flow - 2.59 8.56 9.82 12.1 9.38
ROE (net income / shareholders' equity) - 29% 50.6% 84.9% 17.6% 13.4%
ROA (Net income/ Total Assets) - 4.73% 9.43% 19.6% 8.74% 7.19%
Assets 1 - 31.23 41.9 50.91 107.5 184.7
Book Value Per Share 2 0.3500 0.4700 0.7800 0.0200 0.1100 0.1300
Cash Flow per Share 2 0.0800 0.1100 0.4600 0 0.0100 0
Capex 1 4.49 1.98 0.61 1.7 0.43 2.13
Capex / Sales 38.42% 7.03% 1.56% 2.68% 0.66% 3.03%
Announcement Date 3/30/22 3/30/22 3/30/22 3/30/22 10/28/22 10/31/23
1MYR in Million2MYR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

1st Jan change Capi.
CENGILD MEDICAL Stock Cengild Medical
-7.46% 54.15M
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-20.16% 16.21B
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
+4.50% 12.44B
IHH HEALTHCARE Stock IHH Healthcare
+3.98% 11.58B
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+9.72% 10.79B
ENCOMPASS HEALTH CORPORATION Stock Encompass Health Corporation
+23.61% 8.26B
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-2.19% 7.68B
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+20.75% 7.2B
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+4.49% 6.67B
GLOBAL HEALTH LIMITED Stock Global Health Limited
+50.89% 4.66B
Hospitals, Clinics & Primary Care Services
  1. Stock Market
  2. Equities
  3. CENGILD Stock
  4. Financials Cengild Medical